TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Tm Bioscience Corporation will release financial results for its third quarter on Monday, November 7th, 2005 before market open. Following the release, Tm Bioscience will hold an analyst conference call at 8:30am (EST) hosted by Mr. Greg Hines, President and CEO, and Mr. Jim Pelot, Chief Financial Officer.
DATE: November 7th, 2005 TIME: 8:30 am, Eastern Standard Time WEBCAST: A live audio webcast of the call will be available at www.tmbioscience.com. Webcast attendees are welcome to listen to the conference in real-time or on-demand at your convenience. The webcast will be archived for 90 days. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. About Tm Bioscience - Putting the Human Genome to Work(TM)
Tm Bioscience is a DNA-based diagnostics company developing a suite of genetic tests. Tm Bioscience’s product pipeline includes tests for genetic disorders, drug metabolism, and infectious diseases. Tm Bioscience is located in Toronto, Ontario. Additional information about Tm Bioscience can be found at www.tmbioscience.com.
Tm Bioscience
CONTACT: In Canada: James Smith, The Equicom Group, Investor and MediaInquiries, (416) 815-0700 ext.229, (416) 815-0080 (fax),jsmith@equicomgroup.com; In the United States: Sharon L. Weinstein, EuroRSCG Life NRP, Investor and Media Inquiries, (212) 845-4271, (212) 845-4260(fax), sharon.weinstein@eurorscg.com; To request a free copy of thisorganization’s annual report, please go to http://www.newswire.ca and clickon Tools for Investors.
